Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Head and Neck Neoplasms 1Ependymoma 1Craniopharyngioma 1Central Nervous System Neoplasms 1

Interventions

Vincristine 8X-Rays 6Temozolomide 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Cyclophosphamide 6Specimen Handling 5Irinotecan 5Nuclear Medicine Department, Hospital 4Biopsy 4Radiotherapy 3Radiation 3Dactinomycin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2fludarabine 2ensartinib 2Vinorelbine 2Proton Therapy 2LY3023414 2Ifosfamide 2Filgrastim 2Etoposide 2Doxorubicin 2Dexrazoxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Methionine × 90 days × Clear all
NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡